Metabolix, Inc. (NASDAQ:MBLX), a bioscience company focused on
developing clean, sustainable solutions for plastics, chemicals and
energy, announced today that it will be releasing its second quarter
2009 financial results after the market close on Wednesday, July 29,
2009. The full text of the earnings release will also be available on
the Company’s website at www.metabolix.com.
Richard Eno, the Company’s President and CEO, and Joseph Hill, CFO, will
host a conference call on the same day at 4:30 p.m. (Eastern) to discuss
the results of the second fiscal quarter ended June 30, 2009, and answer
questions from the investor audience. To participate, dial toll-free
1-800-260-6066 or 1-913-312-1278 (international). The passcode is
8148088. The conference call will be webcast and can be accessed from
the Company’s website at www.metabolix.com
in the investor relations section.
To listen to a telephonic replay of the conference call, dial toll-free
1-888-203-1112 or 1-719-457-0820 for international callers and enter
passcode 8148088. The replay will be available beginning at 7:30 p.m.
(Eastern) on Wednesday, July 29, 2009 and will last through 11:59 PM
(Eastern) August 5, 2009. In addition, the webcast will be archived on
the Company’s website in the investor relations section.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation driven bioscience
company focused on providing sustainable solutions for the world’s needs
for plastics, chemicals and energy. The Company is taking a systems
approach, from gene to end product, integrating sophisticated
biotechnology with advanced industrial practice. Metabolix is now
developing and commercializing Mirel™, a family of high performance
bioplastics which are biobased and biodegradable alternatives to many
petroleum based plastics. Metabolix is also developing a proprietary
platform technology for co-producing plastics, chemicals and energy,
from crops such as switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com.
(MBLX-E)
ICR
Anthony Gallo, 203-682-8335 (Investor Relations)
ir@metabolix.com
